Josamycin propionate manufacturers

An isocratic liquid chromatographic method is described using as stationary phase the very stable poly(styrene–divinylbenzene) PLRP-S (8 μm, 1000 Å). The mobile phase was acetonitrile– M phosphate buffer, pH –water (52:20:up to 100, v/v/v), delivered at a flow-rate of ml/min. UV detection was performed at 232 nm. The column was heated at 60°C. Josamycin propionate was separated from all impurities which were present in commercial samples. The main impurities were josamycin, leucomycin A4 propionate, josamycin 2′,9-dipropionate, josamycin 3″,9-dipropionate and platenomycin A1 propionate. Full factorial design was applied to evaluate the robustness of the method.

Josamycin propionate, a tasteless josamycin derivative suitable for the preparation of paediatric oral suspension, was employed in a large, multicentre clinical study aimed at evaluating the effectiveness and safety of the drug. Two hundred paediatric practitioners participated in the study, and 1908 children (mean age years) were treated. Respiratory and pararespiratory infections were the most common diagnosis. The mean daily dose of josamycin was mg/kg and the drug was administered for an average of days. Josamycin proved to be a highly effective antimicrobial agent for the treatment of infections occurring in paediatric practice, with a success rate of %. The drug also showed a high degree of acceptance by the young patients and was very well tolerated: only 98 children (%) developed side-effects during the treatment. However, the side-effects observed were reliably attributable to josamycin in only 10 out of 300 subjects who were not receiving other drugs; among these the frequency rate was %.

Josamycin propionate manufacturers

josamycin propionate manufacturers


josamycin propionate manufacturersjosamycin propionate manufacturersjosamycin propionate manufacturersjosamycin propionate manufacturersjosamycin propionate manufacturers